Clinical Vascular Access Products

Reducing Infection, Enhancing Care

Innovative solutions designed to lower the risk of bloodstream infections during vascular access procedures

Up to 70% of hospitalised patients require at least one PIVC at some point during their hospital stay1-4 In an international cross-sectional study5 across 51 countries comparing insertion techniques and management practices with recommended care, widespread variation was noted. For example, PIVCs were:

  • Inserted at inappropriate sites (69%)
  • Covered with substandard dressings (20%)
  • Showing visible signs of redness and swelling at the insertion site (10%)
  • Malfunctioning  for example, leaking (10%)
  • In place but not used in the preceding 24 hours (14%).

 Up to 69% of PIVCs are associated with complications, leading to up to 90% of PIVCs being removed before therapy is finished.2,3,5,6

These infections are increasingly viewed as preventable adverse events and patients may require additional treatment which increases health care costs to the patient, the organisation and the health system.

  1. Cooke M et al. PLoS One 2018;13(2):e0193436.
  2. Helm RE et al. J Infus Nurs 2015 May–Jun;38(3):189–203.
  3. Marsh N et al, J Hosp Med 2018 Feb 1;13(2):83–9.
  4. Zingg W et al Int J Antimicrob Agents 2009;34 Suppl 4:S38–42.
  5. Alexandrou E et al, J Hosp Med 2018 May 30;13(5).
  6. Wallis MC et al. Infect Control Hosp Epidemiol 2014 Jan;35(1):63–8.9

Intravenous Cannulation

Effective Site Prep. Secure Fixation.

Midline and Central Cannulation

Streamlined Solutions for Midline and PICC Prep

Haemodialysis

Protecting Patients with Safer Dialysis

Difficult Intravenous Cannulation

Precision Tools for Challenging IVs